Id基因对肺高血压发展在左心衰竭中的作用
Christelle Lteif1, Paula Wachs1, Ravindra K Sharma2
1Center for Pharmacogenomics and Precision Medicine, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, FL, USA.
American heart journal plus : cardiology research and practice
|February 24, 2026
概括
Id 基因在肺高血压 (HF-PH) 的心力衰竭中发挥作用. ID2中的遗传变异可能会降低HF患者的PH风险和死亡率,这表明需要进一步研究.
科学领域:
- 心血管生物学 心血管生物学
- 分子遗传学 分子遗传学
- 肺部医学 肺部医学
背景情况:
- 肺高血压 (PH) 是心力衰竭 (HF) 的严重并发症.
- 差异化抑制剂 (Id) 基因在HF-PH的发病过程中的作用尚不清楚.
研究的目的:
- 研究Id基因在HF-PH发育中的参与.
- 评估ID基因中的遗传变异与HF-PH和死亡率的关联.
主要方法:
- 一项实验研究使用AKR/J小鼠模型的HF-PH.
- 一项利用英国生物银行队列的遗传关联研究.
- 对小鼠组织中的Id基因表达和人类参与者的单核酸多态 (SNP) 的分析.
主要成果:
- 在HF-PH小鼠的左心室中,Id1被上调,而在脂肪组织中,Id1和Id3被下调,而Id2被上调.
- 塔克罗利马斯治疗在小鼠中加剧了PH和透缩功能障碍,增加了脂肪组织中的Id2表达.
- 特定的ID2SNP (rs7425561和rs10174593) 显示HF患者降低PH风险和全因死亡率的趋势.
结论:
- Id1,Id2和Id3基因与HF-PH的发病有关.
- 需要进一步的研究来阐明这些Id基因在HF-PH中的确切作用.
更多相关视频
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
703
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
703
Cardiomyopathy III: Hypertrophic Cardiomyopathy
555
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555
Mitral Stenosis I: Introduction
906
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
906
Mitral Regurgitation I: Introduction
697
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
697
Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K


